and fibrosis in the kidney. In vitro, we also found that blockade of Rho kinase with inhibitor Y-27632 prevented high-glucose-induced loss of megalin expression and an increase of TGF-␤ 1 , thereby increasing the absorption rate of FITC-labeled albumin by tubular epithelial cells. Conclusion: ROCK1 may play a role in the development of albuminuria in DKD by downregulating the endocytosis receptors complex -megalin/cubilin.
Introduction
Type 2 diabetes mellitus is a global epidemic disease and is the leading cause of end-stage renal disease. Diabetic kidney disease (DKD) occurs in approximately 20-30% of all diabetic subjects, representing a continuum from microalbuminuria to the overt nephropathy or macroalbuminuria, and finally end-stage renal disease [1] . However, the underlined mechanisms of the pathogenesis of microalbuminuria in the early stage of DKD remain largely unclear.
Increasing evidence shows that albuminuria is a marker and mediator for progressive DKD and is associated with decreased albumin endocytosis that is mediated by dysregulation of megalin expression [2] . Reduced megalin-and cubilin-mediated endocytosis of albumin has been induced by transforming growth factor (TGF)-1 in vitro in proximal-tubule-derived opossum kidney cells [3] .
Activation of Rho kinase has been verified in DKD [4, 5] and pharmacologic inhibition of Rho kinase has been shown to be protective against DKD [6] . As a potential mediator of renal disease, Rho and its downstream effectors, Rho-associated coiled coil-forming protein serine/ threonine kinase (Rho kinase or ROCK), has been well studied in a variety of cellular responses [7, 8] , including cell adhesion, actin dynamics and regulation of gene transcription. In addition, Rho kinase has also been shown to play a critical role in endocytosis, epithelialmesenchymal transition, and fibrosis [9] .
In the present study, we tested a hypothesis that the development of albuminuria in the early stage of DKD may occur via the mechanism of Rho kinase-induced loss of megalin/cubilin-mediated endocytosis of albumin by tubular epithelial cells. This hypothesis was examined in a mouse diabetic model induced in ROCK1 gene knockout mice by streptozotocin (STZ) and in vitro by blocking Rho kinase with a pharmacological inhibitor.
Materials and Methods

Animal Model of DKD Induced in ROCK1 Knockout
Mice by STZ Characterization of ROCK1 knockout (KO) and wild-type (WT) mice (FVB background) has been described previously [10] . Deletion of ROCK1 from the kidney was confirmed by Western blot as previously described [11] ( fig. 1 a) .
A mouse DKD model was induced in littermate ROCK1 WT and KO mice (20-30 g body weight, 2 months of age) by STZ (Sigma-Aldrich, St. Louis, Mo., USA) 50 mg/kg intraperitoneally for 5 consecutive days as recommended by AMDCC (Brosius 2009). Fasting blood glucose taken from the tail was monitored by blood glucose meter (Optium Xceed TM Diabetes Monitoring System, Vic., Australia) every 2 weeks. Control mice were injected with the citrate buffer. Groups of 6 mice were killed on week 8 after STZ or citrate buffer injection. Samples of renal cortex were collected for histology, immunohistochemistry, Western blot, and real-time PCR analyses. Urine samples were collected after 16 h for the assay of urinary albumin excretion.
Urinary Albumin Excretion Assay
Urinary albumin excretion was measured by competitive ELI-SA as recommended by AMDCC (Brosius 2009). Briefly, albumin at a concentration of 5 g/ml in PBS was coated in an ELISA plate (MaxiSorp Surface Immuno Plates TM ; Nunc, Roskilde, Denmark) overnight. After PBS washing three times, 100 l of a standard (albumin 0.2-25 g/ml; ICN Biomedicals, Aurora, Ohio, USA) or urine sample (diluted 1: 20) were added into the wells together with anti-albumin antibody (1: 5,000; ICN Biomedicals) shaking at room temperature for 1 h. After extended washing, ABTS was added into wells for full developing while avoiding light. OD values were read at 410 nm and concentrations were automatically calculated by a program according to the standard curve.
Histology and Immunohistochemistry
Changes in histology were examined in methyl Carnoy-fixed, paraffin-embedded tissue sections (3 m). To evaluate the kidney fibrosis (collagen accumulation), picrosirius red and fast green staining were used in paraffin-embedded kidney sections. Highpower fields ( ! 400) of renal cortex were randomly scanned by using a microscope equipped with a digital camera, and quantitative evaluation was performed with Image-Pro software (MediaCybernetics, Inc., Silver Spring, Md., USA). The scores of 5-7 separate mice in each group were averaged.
A microwave-based antigen retrieval method was used for immunohistochemistry as described previously [12] . After being microwaved, sections were incubated with rabbit polyclonal antibody to cubilin (Santa Cruz Biotechnology, Santa Cruz, Calif., USA) using a two-layer peroxidase anti-peroxidase method. Sections were developed with diaminobenzidine, counterstained with hematoxylin, and coverslipped in an aqueous mounting medium. An isotype rabbit IgG (Sigma) was used as negative control in the study.
Western Blot Analyses
Protein from kidney cortex was extracted with RIPA lysis buffer for Western blot analysis as described previously [3, 13] . Briefly, samples were heated at 99 ° C for 10 min, loaded into wells of 7-20% gel and then transferred to a nitrocellular membrane. Non-specific binding to the membrane was blocked for 1 h at room temperature with 5% fat-free milk in Tris-buffered saline buffer. The membranes were then incubated overnight at 4 ° C with primary antibodies, including rabbit antibody against megalin, cubilin, ROCK1 and TGF-␤ 1 (Santa Cruz Biotechnology), and glyceraldehyde-3-phosphate dehydrogenase (GAPDH; Chemicon, Temecula, Calif., USA). After washing, the membrane was incubated with an IRDye-800-conjugated goat anti-rabbit or rabbit anti-mouse antibody (Rockland Immunochemicals, Gilbertsville, Pa., USA) diluted 1: 20,000 in 5% fat-free milk in TBST for 1 h and signals were detected using an Odyssey Infrared Imaging System (Li-COR Biosciences, Lincoln, Nebr., USA).
Real-Time PCR
Total RNA from renal cortex or cells was isolated using the RNeasy kit, according to the manufacturer's instructions (Qiagen, Valencia, Calif., USA). Real-time PCR was run with the Opticon real-time PCR machine (MJ Research, Waltham, Mass., USA) as previously described [14] . The specificity of real-time PCR was confirmed via the melting-curve analysis. Housekeeping gene GAPDH was used as an internal standard. The primers used in this study are as follows: megalin (mouse), forward 5 -AGGCCACCAGTTCACTTGCT-3 , reverse 5 -AGGACACGCC-CATTCTCTTG-3 ; cubilin (mouse), forward 5 -GGGATCCT-CTCAGGGACACA-3 , reverse 5 -TGCTGGCCGATTCTAAAT-CAA-3 ; TGF-␤ 1 (mouse): forward 5 -CAACAATTCCTGGC-GTTACCTTGG-3 , reverse 5 -GAAAGCCCTGTATTCCGTCT-CCTT-3 ; IL-1 ␤ (mouse): forward 5 -CTTCAGGCAGGCAG-TATCACTCAT-3 , reverse 5 -TCTAATGGGAACGTCACACA-CCAG; GAPDH (mouse), forward 5 -TGCTGAGTATGTCGT-GGAGTCTA-3 and reverse 5 -AGTGGGAGTTGCTGTTGAA-ATC-3 ; megalin (rat), forward 5 -ACCGCCGCAATGCCGC-TGACT-3 , reverse 5 -TGCCCCAATGCCATAGGTAACGA-3 ; GAPDH (rat), forward 5 -CCTGGAGAAACCTGCCAAGTA-TGA-3 and reverse 5 -TTGAAGTCACAGGAGACAACCTGG-3 . Ratios to GAPDH were calculated for each sample and expressed as means 8 SEM.
In vitro Studies
To study the mechanism of ROCK1 in the process of endocytosis, a well-characterized normal rat kidney TEC line (NRK52E) was used. NRK52E cells were grown in low-glucose (5 mmol/l) Dulbecco's modified Eagle's medium (Hyclone, Logan, Utah, USA) containing 5% fetal bovine serum, 60 g/ml penicillin, and 100 g/ml streptomycin in a 5% CO 2 atmosphere at 37 ° C. After 24 h starvation with serum-free DMEM-low glucose, DMEMhigh glucose (25 mmol/l) was used for culture of 0, 3, 6, 12, 24 or 72 h. Cells cultured with DMEM-low glucose was used as control and mannitol at concentration of 25 mmol/l was used as osmotic control. To investigate the role of Rho kinase under high-glucose conditions, a ROCK pharmacological inhibitor, Y-27632 (Sigma-Aldrich), was added into the cells (1 M ) 1 h before highglucose stimulation.
Flow Cytometry of FITC-Albumin for the Assay of Cell Endocytosis
After treatment with high glucose for 72 h, FITC-albumin (Sigma-Aldrich) diluted to 10 g/ml in DMEM-low glucose was added into 6-well plates at 37 ° C for 30 min. Control cells were incubated with FITC-albumin at 4 ° C for 30 min. The cells were then trypsinized and washed with PBS twice before they were analyzed with a Cytomics FC 500 Flow Cytometer (Beckman Coulter Inc., Fullerton, Calif., USA). For all the above processes, light was avoided. Mean intensity of fluorescence minus background binding of FITC at 4 ° C was recorded as the FITC-albumin phagocytosed by cells.
Statistical Analyses
Data obtained from this study are expressed as the mean 8 SEM of at least three independent experiments or 6 mice from one group of mice. Statistical analyses were performed using one-way analysis of variance followed by Newman-Keuls post-test using the GraphPad Prism 4.0 (GraphPad Software, Inc., San Diego, Calif., USA).
Results
ROCK1 KO Mice Are Protected against Albuminuria in STZ-Induced Diabetic Mice
Characterization of ROCK1 KO mice was confirmed by absence of ROCK1 protein expression detected by Western blot analysis ( fig. 1 a) . A mouse model of diabetes was successfully induced by STZ in both ROCK1 WT and KO mice as demonstrated by an equal level of increased blood glucose ( fig. 1 b) . However, while ROCK1 WT mice developed a significant albuminuria at 8 weeks after STZ injection, ROCK1 KO mice had a normal level of urinary albumin excretion throughout the disease course ( fig. 1 c) .
Deletion of ROCK1 Prevents a Loss of Megalin/Cubilin in Kidneys with Diabetes
We then examined the potential mechanisms by which ROCK1 KO mice were protected against the development of albuminuria in diabetes by examining expression of megalin/cubilin in the cortex of kidneys. Analysis using real-time PCR, Western blot, and immunohistochemistry showed expressions of megalin and cubilin by tubular epithelial cells, presumably as proximal tubular epithelial cells were largely reduced in Wt mice with diabetes. In contrast, diabetic mice lacking ROCK1 gene exhibited normal expression levels of megalin and cubilin ( fig. 2 ac) . Interestingly, Western and real-time PCR showed that deletion of ROCK1 resulted in a significant inhibition of TGF-␤ 1 mRNA and protein expression in the diabetic kidney ( fig. 3 a, b) . Meanwhile, the same changes were also found in expression of IL-1 ␤ mRNA and collagen matrix accumulation in the diabetic kidney ( fig. 3 c, d ).
ROCK Inhibitor Y-27632 Inhibits High-Glucose-Induced Loss of Megalin, Increases Cytophagosis of Albumin, and Blocks Upregulation of TGF-␤ 1 by NRK52E in vitro
To explore the mechanism of the functional role of ROCK1 in the development of albuminuria in DKD, we performed in vitro studies in a NRK52E rat tubular epithelial cell line under conditions of high glucose and in the presence or absence of a ROCK inhibitor Y-27632. As shown in figure 4 , high glucose (25 m M ), but not mannitol control, induced a significant loss of megalin at the mRNA level at 6 h ( fig. 4 a) and the protein level at 24 h ( fig. 4 b) , which was prevented by a ROCK inhibitor Y-27632 (1 M ) ( fig. 4 a, b) . Furthermore, using flow cy- tometry, we also demonstrated that high glucose was able to impair cytophagosis of FITC-albumin by NRK52E tubular epithelial cells, which was prevented by addition of ROCK inhibitor ( fig. 5 a) . Interestingly, high-glucose-induced upregulation of TGF-␤ 1 was also blocked by a ROCK inhibitor ( fig. 5 b) .
Discussion
This study showed that deletion of ROCK1 protected against the development of albuminuria in a mouse model of DKD induced by STZ. This finding is consistent with the protective effect of ROCK inhibitor, fasudil, in a STZinduced mouse model and in db/db mice [5, 6, 15] . The novel finding from the present study was that Rho kinase mediated albuminuria via the megalin/cubilin-dependent mechanism because prevention from the development of albuminuria in the ROCK1 KO mice was associated with the protection against the loss of megalin/cubilin in DKD mice. Indeed, the development of albuminuria in the early stage of diabetic mice has been shown to be associated with the decrease in albumin endocytosis by tubular epithelial cells due to lower levels of megalin expression as demonstrated by using a functional micropuncture and an immunogold electron microscope technique [2] . It is now clear that the process of reabsorption of albumin from the glomerular filtrate is via the mech anism of receptor-mediated endocytosis by proximal tubular epithelial cells. Megalin/cubilin are members of the low-density lipoprotein receptor family [16] and have been shown to mediate endocytosis of multiple, unrelated ligands via coated pits, leading to delivery of ligands to lysosomes. After binding of albumin to the megalin/cubilin complex in apical alathrin-coated pits, the endocytosis of albumin occurs, followed by degradation in lysosomes. By immunohistochemistry, megalin and cubilin have been found on the apical surface of a restricted group of absorptive epithelial cells, including tubular epithelial cells [17, 18] . Reduced expressions of megalin/cubilin have been found in association with the development of albuminuria in aristolochic acid nephropathy [19] , Dent's disease [20] and autosomaldominant polycystic kidney disease [21] . Thus, protection from a loss of megalin and cubilin in the diabetic mouse kidney could be a key mechanism by which ROCK1 KO mice were protected against the development of albuminuria. This was further supported by the in vitro finding that blockade of Rho kinase with addition of Rho kinase inhibitor rescued a loss of megalin, thereby resulting in an increased absorption rate of FITC-albumin by tubular epithelial cells under high-glucose conditions in vitro. Indeed, proteinuria is the most important predictor of clinical outcomes in both diabetic and non-diabetic nephropathy [22, 23] . A Rho kinase-mediated loss of megalin/ cubilin-dependent endocytosis of albumin could be a mechanism of the development of albuminuria. Once al- buminuria occurs, it can activate the 'albumin-regulated genes' to mediate tubulointerstitial fibrosis as reported recently using Affymetrix microarray [24] .
Inhibition of TGF-␤ 1 expression may be another mechanism by which deletion of ROCK1 prevented the development of albuminuria in diabetic mice and the impairment of albumin endocytosis by tubular epithelial cells. This was supported by the findings that ROCK1 KO mice had lower levels of TGF-␤ 1 but higher levels of megalin/cubilin expression in the diabetic kidney and that blockade of Rho kinase activities with a specific inhibitor inhibited high-glucose-induced TGF-␤ 1 expression and rescued a loss of megalin-mediated albumin uptake by tubular epithelial cells. These findings are consistent with a previous report that addition of TGF-␤ 1 inhibits megalin/cubilin-dependent endocytosis of albumin in proximal tubular epithelial cells derived from opossum kidney cells [3] . It has been shown that albumin is able to activate TGF-␤ signaling and collagen IV expression by proximal tubular cells [25] , suggesting a positive regulatory loop among 'TGF-␤ 1 -megalin/cubulinalbuminuria' during the development of tubulointerstitial fibrosis. Thus, activation of Rho kinase may impair megalin/cubulin-mediated endocytosis of albumin by tubular epithelial cells and results in the development of albuminuria, which, in turn, upregulates TGF-␤ to mediate renal fibrosis. A role of Rho kinase in TGF-␤ -mediated diabetic kidney injury is further demonstrated by a recent study that fasudil treatment is capable of suppressing upregulation of renal TGF-␤ 1 and CTGF, thereby inhibiting renal fibrosis including collagen I and fibronectin expression and, particularly, the epithelial-mesenchymal transition in STZ-induced, uninephrectomized diabetic rats [26] . Thus, inhibition of TGF-␤ -mediated renal fibrosis may be a mechanism by which treatment of Rho kinase inhibitor ameliorates albuminuria in both type 1 and type 2 diabetes [5, 6, 26, 27] . Results from the present study in ROCK1 KO mice provided further evidence for supporting this notion.
Albuminuria is able to activate the inflammatory pathway and induces chemokine and cytokine expression [28] . We also found that inhibition of albuminuria and protection of megalin/cubulin from a loss in diabetic ROCK1 KO mice were also associated with suppression of IL-1 ␤ expression, suggesting that the activation of the inflammatory pathway may downregulate megalin/cubilin-dependent endocytosis of albumin in the early stage of DKD. Therefore, inhibition of renal inflammation could also be a mechanism by which ROCK1 KO mice were protected against the early diabetic kidney injury. ROCK1 and ROCK2 are isoforms of Rho kinase, both of which are active and play an important role in cytoskeletal arrangement [7, 8] , cardiovascular remodeling [29, 30] , liver fibrosis [31, 32] , epithelial-mesenchymal transition [33] [34] [35] and in renal injury such as tubuloin terstitial fibrosis in the mouse model of unilateral ureteral obstruction nephropathy [36, 37] , ischemia/re perfusion-induced acute renal failure [38] , and glomer ulosclerosis in spontaneous hypertensive rats [39] . Studies on ROCK1 KO mice have provided new insights into the role of ROCK1 and ROCK2 in the physiopathological process. It is noticed that ROCK1 KO has a protective role on ischemia/reperfusion cardiomyopathy [40] and cardiac hypertrophic decompensation [41] . Loss of ROCK2 results in placental dysfunction leading to intrauterine growth retardation and fetal death. It has also been reported mice deficient of ROCK1 at 16-18 weeks of age may develop insulin resistance [42] . However, our results with equally high levels of blood glucose in both ROCK1 KO and WT mice over an 8-week period suggest that a longer diabetic time course may be necessary for studying the role of Rho kinase in diabetic kidney complications.
